Jean-Baptiste Lascarrou

Concepts (72)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Out-of-Hospital Cardiac Arrest3202010470.30Why?
Cardiopulmonary Resuscitation4202018760.25Why?
Diet, Protein-Restricted12021800.21Why?
Neuromuscular Blocking Agents120201210.19Why?
Delphi Technique1202112570.16Why?
Pneumonia, Ventilator-Associated220218610.15Why?
Parenteral Nutrition120171840.15Why?
Enteral Nutrition120173200.14Why?
Status Epilepticus120183030.14Why?
False Negative Reactions1202117850.13Why?
Emergency Medical Services2202035570.13Why?
Multiple Organ Failure1202117240.11Why?
Shock1201718680.10Why?
Hypoxia3202136260.10Why?
Respiratory Insufficiency2202173010.09Why?
Heart Arrest1201812390.09Why?
Thrombolytic Therapy1201922180.08Why?
Respiration, Artificial42021221160.08Why?
Consensus1202163450.08Why?
Noninvasive Ventilation1201823290.07Why?
Oxygen Inhalation Therapy1201836290.07Why?
Reproducibility of Results12021113040.07Why?
Vasoconstrictor Agents220187140.07Why?
Registries22020123270.06Why?
Adrenal Cortex Hormones1202065370.06Why?
Intubation, Intratracheal1201839620.06Why?
Case-Control Studies12021176710.06Why?
Reverse Transcriptase Polymerase Chain Reaction12021137200.05Why?
Sensitivity and Specificity12021229710.05Why?
France32021120740.05Why?
Aged820212157760.04Why?
Middle Aged920212706810.04Why?
Tidal Volume120195650.04Why?
Male1020213677250.04Why?
Female1020213803170.04Why?
Survival Rate2202092060.04Why?
Adult620212443710.03Why?
Critical Care12017140810.03Why?
Drug Administration Schedule1202023240.03Why?
Ischemia120219010.03Why?
Humans1420219305980.03Why?
Carbon Dioxide120199170.03Why?
Retrospective Studies520211053220.03Why?
Pulmonary Fibrosis1202110680.03Why?
Dose-Response Relationship, Drug1202037760.03Why?
Electroencephalography1201812420.03Why?
Combined Modality Therapy1201933950.03Why?
Respiratory Tract Diseases1201810610.03Why?
Methylprednisolone1202021070.02Why?
Intensive Care Units32021295940.02Why?
Proportional Hazards Models1202065430.02Why?
Cause of Death1202148230.02Why?
Survival Analysis1201975920.02Why?
Hospital Mortality22021220870.02Why?
Acute Disease1201860290.02Why?
Time Factors22018313970.02Why?
Time-to-Treatment1202058830.02Why?
Forecasting1201844920.02Why?
Pneumonia, Viral220212436840.01Why?
Treatment Outcome22020517320.01Why?
Pulmonary Embolism1201947750.01Why?
Length of Stay12017110420.01Why?
Nervous System Diseases1201840920.01Why?
Critical Illness12021172810.01Why?
Cohort Studies12021360050.01Why?
Prospective Studies12020433010.01Why?
Comorbidity12018347960.01Why?
Cardiovascular Diseases12018114970.01Why?
Coronavirus Infections120202537890.01Why?
Severity of Illness Index12018482260.01Why?
Hospitalization12021542800.01Why?
Pandemics120203892490.00Why?
Lascarrou's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (72)
Explore
_
Co-Authors (179)
Explore
_
Similar People (60)
Explore
_